@70后、80后,逐渐消失的激素,还能补回来!
这些人 推荐用 |
1.绝经相关症状 2.泌尿生殖道萎缩相关问题 3.低骨量及骨质疏松 |
这些人 谨慎用 |
1.子宫肌瘤 2.子宫内膜异位症 3.子宫内膜增生症 4.有血栓形成倾向 5.胆囊疾病 6.癫痫、偏头痛、哮喘 7.系统性红斑狼疮 8.乳腺良性疾病及乳腺癌家族史 |
这些人 禁止用 |
1.已知或怀疑妊娠 2.原因不明的阴道出血 3.已知或怀疑患有乳腺癌 4.已知或怀疑患有性激素依赖性恶性肿瘤 5.最近6个月内患活动性静脉或动脉血栓栓塞性疾病 6.严重肝肾功能不全 7.血卟啉症、耳硬化症 8.已知患有脑膜瘤(禁用孕激素) |
用激素会得癌吗?
足量饮水(1500-1700ml/天);
摄入适量蔬菜和水果、每周摄入>2次鱼类产品;
烹饪时注意少油(25-30g/天)、限盐(≤6g/天)、控糖(≤50g/天);
同时戒烟、限酒(酒精量≤15g/天);
每日规律有氧运动,每周累计150分钟,同时进行2-3次抗阻运动。
参考文献:
[1] Norman R J, Flight I H, Rees M C. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution[J]. Cochrane Database Syst Rev,2000(2):D1018.
[2] Beral V, Bull D, Reeves G. Endometrial cancer and hormone-replacement therapy in the Million Women Study[J]. Lancet,2005,365(9470):1543-1551.
[3] Sjogren L L, Morch L S, Lokkegaard E. Hormone replacement therapy and the risk of endometrial cancer: A systematic review[J]. Maturitas,2016,91:25-35.
[4] Shim S H, Lee S J, Kim S N. Effects of hormone replacement therapy on the rate of recurrence in endometrial cancer survivors: a meta-analysis[J]. Eur J Cancer,2014,50(9):1628-1637.
[5] Rossouw J E, Anderson G L, Prentice R L, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial[J]. JAMA,2002,288(3):321-333.
[6] Moen M H, Rees M, Brincat M, et al. EMAS position statement: Managing the menopause in women with a past history of endometriosis[J]. Maturitas,2010,67(1):94-97.
[7] Manson J E, Chlebowski R T, Stefanick M L, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials[J]. JAMA,2013,310(13):1353-1368.
[8] Davey D A. Menopausal hormone therapy: a better and safer future[J]. Climacteric,2018,21(5):454-461.
[9] Fahlen M, Fornander T, Johansson H, et al. Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial[J]. Eur J Cancer,2013,49(1):52-59.
[10] Lin K J, Cheung W Y, Lai J Y, et al. The effect of estrogen vs. combined estrogen-progestogen therapy on the risk of colorectal cancer[J]. Int J Cancer,2012,130(2):419-430.
[11] Murphy N, Strickler H D, Stanczyk F Z, et al. A Prospective Evaluation of Endogenous Sex Hormone Levels and Colorectal Cancer Risk in Postmenopausal Women[J]. J Natl Cancer Inst,2015,107(10).
[12] Camargo M C, Goto Y, Zabaleta J, et al. Sex hormones, hormonal interventions, and gastric cancer risk: a meta-analysis[J]. Cancer Epidemiol Biomarkers Prev,2012,21(1):20-38.
[13] Hassan M M, Botrus G, Abdel-Wahab R, et al. Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma[J]. Clin Gastroenterol Hepatol,2017,15(11):1791-1799.
[14] Nelson R A, Levine A M, Bernstein L. Reproductive factors and risk of intermediate- or high-grade B-Cell non-Hodgkin's lymphoma in women[J]. J Clin Oncol,2001,19(5):1381-1387.
[15] Sturniolo G, Zafon C, Moleti M, et al. Immunohistochemical Expression of Estrogen Receptor-alpha and Progesterone Receptor in Patients with Papillary Thyroid Cancer[J]. Eur Thyroid J,2016,5(4):224-230.
[16] Brusselaers N, Maret-Ouda J, Konings P, et al. Menopausal hormone therapy and the risk of esophageal and gastric cancer[J]. Int J Cancer,2017,140(7):1693-1699.
[17] Pines A. Hormone therapy and brain tumors[J]. Climacteric,2011,14(2):215-216.
[18] Troisi R J, Speizer F E, Willett W C, et al. Menopause, postmenopausal estrogen preparations, and the risk of adult-onset asthma. A prospective cohort study[J]. Am J Respir Crit Care Med,1995,152(4 Pt 1):1183-1188.
[19] Meier C R, Sturkenboom M C, Cohen A S, et al. Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus[J]. J Rheumatol,1998,25(8):1515-1519.
[20] Yang C H, Lee J N, Hsu S C, et al. Effect of hormone replacement therapy on uterine fibroids in postmenopausal women--a 3-year study[J]. Maturitas,2002,43(1):35-39.
[21] Harden C L, Pulver M C, Ravdin L, et al. The effect of menopause and perimenopause on the course of epilepsy[J]. Epilepsia,1999,40(10):1402-1407.
[22] Nordin B E, Need A G, Morris H A, et al. Evidence for a renal calcium leak in postmenopausal women[J]. J Clin Endocrinol Metab,1991,72(2):401-407.